Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 27.05 is 40% above its 5-year average of 19.31, near the high end of its 5-year range (10.60–30.13).
As of the fiscal period ended Wednesday, December 31, 2025. 4.37% below its 12-month average of 28.29.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
27.05
EARNINGS PER SHARE (EPS) AVG TTM
28.29
EARNINGS PER SHARE (EPS) AVG 3Y
23.40
EARNINGS PER SHARE (EPS) AVG 5Y
19.31
EARNINGS PER SHARE (EPS) AVG 10Y
15.18
EARNINGS PER SHARE (EPS) AVG 15Y
11.81
EARNINGS PER SHARE (EPS) AVG 20Y
9.14
CURRENT VS TTM AVG
-4.37%
CURRENT VS 3Y AVG
+15.61%
CURRENT VS 5Y AVG
+40.11%
CURRENT VS 10Y AVG
+78.23%
CURRENT VS 15Y AVG
+128.95%
CURRENT VS 20Y AVG
+195.87%
United Therapeutics Corporation
Market Cap
$22.23B
Earnings Per Share (EPS)
27.05
TTM Avg
28.29
3Y Avg
23.40
5Y Avg
19.31
Market Cap
$22.14B
Earnings Per Share (EPS)
-8.15
TTM Avg
-8.27
3Y Avg
-1.90
5Y Avg
3.46
Market Cap
$23.38B
Earnings Per Share (EPS)
-5.94
TTM Avg
-4.08
3Y Avg
9.21
5Y Avg
14.48
Market Cap
$20.80B
Earnings Per Share (EPS)
-0.26
TTM Avg
-1.77
3Y Avg
-0.44
5Y Avg
-0.66
Market Cap
$23.72B
Earnings Per Share (EPS)
7.82
TTM Avg
6.79
3Y Avg
7.36
5Y Avg
7.17
Market Cap
$25.02B
Earnings Per Share (EPS)
7.87
TTM Avg
10.78
3Y Avg
11.05
5Y Avg
10.65
Market Cap
$25.77B
Earnings Per Share (EPS)
11.29
TTM Avg
9.71
3Y Avg
9.57
5Y Avg
13.14
Market Cap
$18.52B
Earnings Per Share (EPS)
3.85
TTM Avg
4.00
3Y Avg
3.51
5Y Avg
2.55
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | $22.23B | 27.05 | 28.29 | 23.40 | 19.31 |
| Moderna, Inc. (MRNA)vs › | $22.14B | -8.15 | -8.27 | -1.90 | 3.46 |
| STERIS plc (STE)vs › | $22.45B | 7.93 | 7.08 | 4.77 | 4.37 |
| BioNTech SE (BNTX)vs › | $23.38B | -5.94 | -4.08 | 9.21 | 14.48 |
| Viatris Inc. (VTRS)vs › | $20.80B | -0.26 | -1.77 | -0.44 | -0.66 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.72B | 7.82 | 6.79 | 7.36 | 7.17 |
| Waters Corporation (WAT)vs › | $25.02B | 7.87 | 10.78 | 11.05 | 10.65 |
| Labcorp Holdings Inc. (LH)vs › | $25.77B | 11.29 | 9.71 | 9.57 | 13.14 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.52B | 3.85 | 4.00 | 3.51 | 2.55 |
| Incyte Corporation (INCY)vs › | $25.96B | 7.85 | 3.38 | 2.74 | 2.31 |
Trailing EPS (TTM)
$27.05
Forward EPS (Est.)
$27.87
P/E Ratio
19.4
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 30.13 |
| 2024-12-31 | 26.44 |
| 2023-12-31 | 21.04 |
| 2022-12-31 | 15.98 |
| 2021-12-31 | 10.60 |
| 2020-12-31 | 11.65 |
| 2019-12-31 | -2.39 |
| 2018-12-31 | 13.54 |
| 2017-12-31 | 9.50 |
| 2016-12-31 | 16.29 |
| 2015-12-31 | 14.17 |
| 2014-12-31 | 7.06 |
| 2013-12-31 | 3.49 |
| 2012-12-31 | 5.84 |
| 2011-12-31 | 3.81 |
| 2010-12-31 | 1.89 |
| 2009-12-31 | 0.37 |
| 2008-12-31 | -0.93 |
| 2007-12-31 | 0.47 |
| 2006-12-31 | 1.61 |
| 2005-12-31 | 1.43 |
| 2004-12-31 | 0.36 |
| 2003-12-31 | -0.24 |
| 2002-12-31 | -0.57 |
| 2001-12-31 | -0.92 |
| 2000-12-31 | -1.97 |
| 1999-12-31 | -1.26 |
| 1998-12-31 | -0.77 |
